Song Na, Yang Shikun, Wang Yang-Yang, Tang Shi-Qi, Zhu Ying-Qiu, Dai Qing, Zhang Hao
Department of Nephrology, The Third Xiangya Hospital of Central South University, Changsha, China.
Genet Test Mol Biomarkers. 2019 Aug;23(8):533-556. doi: 10.1089/gtmb.2019.0037.
To determine whether vitamin D receptor () gene polymorphisms are correlated with susceptibility to diabetic vascular complications. We included all eligible studies, and used Stata12.0 to calculate the pooled results. Eight thousand eleven diabetic patients and 1635 normal controls from 27 studies were included. Our results showed that there was no correlation between gene I variants and diabetic nephropathy (DN) or diabetic retinopathy (DR) susceptibility. In comparison with diabetic patients without DN, there was a link between the gene I variant and DN susceptibility under allelic model ( = 0.029) in all populations. In addition, the gene I variant correlated with DN under both dominant ( = 0.005) and allelic ( = 0.003) models in Asian populations. The gene I variant was also correlated with DN susceptibility under the recessive model ( = 0.027) in the Asian subgroup. In comparison with diabetic patients without DR, we identified a link between the gene I variant and DR susceptibility under the dominant model ( = 0.034) in all populations. Also, the gene I variant was correlated with DR under the recessive ( = 0.016), the allelic ( = 0.001), and the dominant ( < 0.001) models in all populations. When compared with healthy controls, the gene I variant was associated with DR under the additive ( = 0.014), the allelic ( = 0.033), and the dominant ( < 0.001) models in Indian populations. The gene I, I, and I gene variants are associated with DN and DR susceptibility. No association was found between the gene I gene variants and diabetic vascular complications.
为确定维生素D受体()基因多态性是否与糖尿病血管并发症的易感性相关。我们纳入了所有符合条件的研究,并使用Stata12.0计算汇总结果。纳入了来自27项研究的8011例糖尿病患者和1635例正常对照。我们的结果显示,基因I变异与糖尿病肾病(DN)或糖尿病视网膜病变(DR)易感性之间无相关性。在所有人群中,与无DN的糖尿病患者相比,基因I变异与等位基因模型下的DN易感性之间存在关联(=0.029)。此外,在亚洲人群中,基因I变异在显性(=0.005)和等位基因(=0.003)模型下均与DN相关。在亚洲亚组中,基因I变异在隐性模型下也与DN易感性相关(=0.027)。与无DR的糖尿病患者相比,我们发现在所有人群中,基因I变异与显性模型下的DR易感性之间存在关联(=0.034)。同样,在所有人群中,基因I变异在隐性(=0.016)、等位基因(=0.001)和显性(<0.001)模型下均与DR相关。与健康对照相比,在印度人群中,基因I变异在相加(=0.014)、等位基因(=0.033)和显性(<0.001)模型下与DR相关。基因I、I和I基因变异与DN和DR易感性相关。未发现基因I基因变异与糖尿病血管并发症之间存在关联。